Das Arzneimittel Kompendium
45
Quality Score
Emerging
✍️ Bumetric analysis
“
Das Arzneimittel Kompendium is an iOS app from treeinspired GmbH in the Education category, currently rated 4.0★ across 1 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 45: Emerging (early traction worth watching). For a Education app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$1.1K
per month
→
12-mo forecast
$990 – $3570
per month
→
24-mo forecast
$918 – $8259
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
5 snapshots on record
Rating
4.0
Reviews
1 reviews
Forecast Revenue / mo
$1.1K
Snapshots tracked
5
since Mar 2026
🤖Also on Android
—/mo · no ratings
View →
ONE-TIME · BUILD
💰 Estimated build cost
$160K
↳ What it cost to build · not monthly revenue
Likely range $120K – $215K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
| ⚙ 16.3y maintenance × ~1-person team | +$98K |
Total estimate
$160K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$20K
↳ What it would sell for · not monthly revenue
Marketplace range $15K – $25K · 18× MRR multiple
💸
~0.1× build cost (under-water)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| 📅 16.3y proven track record | +20% |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
18× MRR
🛠 Estimated tech stack
🍎
Native iOS (Swift / UIKit)
Medium confidence · 70%
Also possible
Flutter
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
Signals we read
| 📦 App bundle size | 38 MB |
| 🏷 Category context | Education |
| 📦 Small-mid iOS bundle | → Native Swift / UIKit (pre-2020 era) |
💀 Maintenance status
Likely abandoned
95%
Last shipped 2021-10-13 · 1810 days ago
0 · Active
50 · At risk
100 · Abandoned
Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.
Risk signals
| 📅 4y+ since last update | Likely abandoned |
| 👥 Small user base (1 ratings) + 16.3y old | +10% (solo-project pattern) |
| • 16y old + 1y+ no update | +5% (API deprecation drift) |
Verdict
Likely abandoned
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$1.1K/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$964 – $2.2K
12 months
$990 – $3.6K
24 months
$918 – $8.3K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Pre-traction · 38/100INDIE TIERlimited signalGrowth Velocity
5.0
Founder Strength
3.0
Product Quality
3.2
Revenue Strength
3.1
Monetization Maturity
1.0
Defensibility
6.0
Market Position
2.0
Operational Safety
7.0
- 💰 Revenue: Modest — $453 - $2832/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.0★ across 1 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 1803d ago — possibly dormant.
- ⚠️ Risk: Moderate — dormant (1803d since update).
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $20K-$36K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 6 of 6 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| bugsREVIEW | −$1,800 | |
| Mature app (16y old)METRIC | +$1,500 | |
| Multilingual (24 languages)METRIC | +$1,500 | |
| Good rating (4.0★)METRIC | +$800 | |
| Pre-traction phase (1 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v6.2
- iOS 15 Improvements
- Bugfixing
- Bugfixing
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Das Arzneimittel Kompendium
- Developer
- treeinspired GmbH
- Bundle ID
- XBAD4N6BA4.com.treeinspired.kompendium
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 12+
- Languages
- BG, CA, HR, CS, DA, NL, EN, ET, FI, FR, DE, EL, HU, IT, LV, LT, MT, PL, PT, RO, SK, SL, ES, SV
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- Model estimate / mo
- $1.1K/mo
- Top-grossing rank
- 🇫🇷#80 /100
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
🗺️Geographic Distribution1 of 9 markets
🇫🇷
FR
Top-grossing rank: #80 / 100
Other markets
Outside top 100
in US, GB, DE, FR, JP, CA, AU, BR, IN
in US, GB, DE, FR, JP, CA, AU, BR, IN
This app currently ranks in only one of the 9 markets we monitor. Niche or regional apps often launch this way before global rollout. Rankings update daily.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Compendium contains the complete data set of medicines approved in the USA, Switzerland, or Spain, based on your language selection.
The application provides medical professionals with detailed information about the drugs approved for use in the United States, Switzerland, Spain and Europe (BG, CS, DA, DE, EL, EN, ES, ET, FI, FR, HR, HU, IT, LT, LV, MT, NL, PL, PT, RO, SK, SL, SV)
The long process of leafing through and searching is over. Using the search function, you can find all the information within seconds.
Language of the data: English / Spanish / German / French… View full description on the official store →
The application provides medical professionals with detailed information about the drugs approved for use in the United States, Switzerland, Spain and Europe (BG, CS, DA, DE, EL, EN, ES, ET, FI, FR, HR, HU, IT, LT, LV, MT, NL, PL, PT, RO, SK, SL, SV)
The long process of leafing through and searching is over. Using the search function, you can find all the information within seconds.
Language of the data: English / Spanish / German / French… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 38 MB🔞 12+📱 iOS 13.0+🔖 v6.2🔄 updated 4y ago🌐 BG, CA, HR, CS, DA +19📂 Education💰 Free🚀 Launched 2010 (16y old)
📅
What Worked™ · Development Pipeline
3 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
🔄
Monetization changed: paid → free
2026-05
⭐
Rating ↑ 3.00 → 4.00 (improved 1.00★)
2026-03
🚀
First tracked snapshot — initial data captured
🌍
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 0★ | 0 | — |
| 🇧🇷 BR | 0★ | 0 | — |
| 🇨🇦 CA | 0★ | 0 | — |
| 🇩🇪 DE | 3★ | 5 | 3★ this version |
| 🇫🇷 FR | 3★ | 15 | 3★ this version |
| 🇬🇧 GB | 5★ | 1 | 5★ this version |
| 🇮🇳 IN | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇺🇸 US | 4★ | 1 | 4★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by treeinspired GmbH
View all →📦 Portfolio summaryINDIE studio
2apps·$1K/mocombined
⚠ Concentrated — top app contributes 100% of combined revenue (single-app dependency)
About this analysis
Why low confidence: only 1 rating · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
Das Arzneimittel Kompendium is a very early-stage iOS app in the education space with weak public traction — only 1 rating, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
7 answers · auto-generated from this app's public dataHow much does Das Arzneimittel Kompendium make per month?▴
Low-confidence model estimate. Das Arzneimittel Kompendium has only 1 App Store rating, so our revenue model has very little signal to work with — treat the ~$1.1K/mo figure as directional only, not a verified MRR. No founder-verified revenue data is available for this app. See methodology for the formula and confidence bands.
What apps are like Das Arzneimittel Kompendium?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is Das Arzneimittel Kompendium built with?▴
Our heuristic places Das Arzneimittel Kompendium on the Native iOS (Swift / UIKit) stack (Medium confidence, 70%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Flutter.
Is Das Arzneimittel Kompendium still actively maintained?▴
Maintenance status: Likely abandoned (95% abandonment risk). Last shipped version was 4+ years ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
When was Das Arzneimittel Kompendium last updated?▴
Das Arzneimittel Kompendium last shipped a new version on 2021-10-13 — more than 4 year(s) ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes Das Arzneimittel Kompendium?▴
Das Arzneimittel Kompendium is published by treeinspired GmbH on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Das Arzneimittel Kompendium's BU Score?▴
Das Arzneimittel Kompendium has a BU Score of 45/100 (Emerging). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.